PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1532773
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1532773
Cell Processing Instruments Market size was valued at USD 6,009.90 Million in 2023, expanding at a CAGR of 7.02% from 2024 to 2032.
Cell processing instruments form a specialized arsenal for researchers and clinicians, designed to isolate, manipulate, and analyze cells for various applications. Tools like centrifuges are used to separate different cell types, while flow cytometers sort cells based on specific properties. Cell counters assess viability, and bioreactors provide controlled environments for cell growth. Micromanipulators enable the delicate handling of individual cells. This diverse range of instruments is essential for successful cell culture, processing, and the advancement of cell-based therapies and regenerative medicine.
Cell Processing Instruments Market- Market Dynamics
Rapid healthcare infrastructure growth to propel market demand
The market growth can be attributed to the increasing prevalence of chronic diseases, rising investments in research and development, and the growing number of clinical trials for cell-based therapies. Furthermore, the increasing number of collaborations and partnerships among market players is also expected to positively impact market growth. For example, in February 2024, Thermo Fisher Scientific Inc. and Multiply Labs expanded their partnership to automate cell therapy production through a combination of robotics and automation of instruments, aiming to reduce the manufacturing space required for producing cell therapies. The market had a positive impact during the pandemic. Several factors, such as the growing demand for vaccines and therapies, accelerated market growth during the COVID-19 period. Additionally, the pandemic underscored the potential of various cell-based therapies for treating infectious diseases, immune disorders, and many other conditions. Thus, increasing awareness and interest in cell therapies have further bolstered market growth. Moreover, significant government investments were made in developing COVID-19 vaccines and treatments, thereby propelling market growth.
Cell Processing Instruments Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.02% over the forecast period (2024-2032)
Based on Product type segmentation, cell separator systems was predicted to show maximum market share in the year 2023
Based on application segmentation, cell separation/isolation was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Cell Processing Instruments Market is segmented on the basis of Product type, Application, End User, and Region.
The market is divided into six categories based on Product type: cell counters, cell imaging systems, flow cytometers, cell separator systems, automated cell processing systems, and other instruments. The cell separator systems segment led the market with the largest revenue share of 22.25% in 2023, driven by continuous technological advancements. Modern cell separator systems now incorporate automation, real-time monitoring, and integration with advanced analytical techniques, enabling high-throughput processing and precise cell isolation. For example, in February 2024, Multiply Labs and Thermo Fisher Scientific extended their partnership to automate cell expansion and separation in cell therapy manufacturing. Multiply Labs' robotic technology is utilized to automate Thermo Fisher's state-of-the-art, GMP-ready instruments, aiming to reduce costs and expedite timelines, thereby enhancing the scalability and accessibility of cell therapy. This collaboration is expected to further stimulate market growth over the forecast period.
The market is divided into four categories based on application: cell separation/isolation, cell imaging & counting, cell viability & proliferation, and other applications. The cell separation/isolation segment held the largest revenue share in 2023. Advances in cell isolation and separation technologies have led to the development of more sophisticated and efficient instruments, including microfluidic systems, magnetic cell sorting technologies, and automated platforms. These technologies offer higher throughput, improved purity, and reduced processing times. For instance, in October 2023, Akadeum Life Sciences announced the preview of their Alerion cell separation system, utilizing Buoyancy Activated Cell Sorting (BACS) microbubble technology to efficiently isolate T-cells from leukopaks. This innovative system promises accelerated separation, increased recovery, automated processes, and reduced errors, thus anticipated to drive market growth over the forecast period.